The effect of population-based blood pressure screening on long-term cardiometabolic morbidity and mortality in Germany: A regression discontinuity analysis.
<h4>Background</h4>Hypertension represents one of the major risk factors for cardiovascular morbidity and mortality globally. Early detection and treatment of this condition is vital to prevent complications. However, hypertension often goes undetected, and even if detected, not every pa...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-12-01
|
| Series: | PLoS Medicine |
| Online Access: | https://doi.org/10.1371/journal.pmed.1004151 |
| _version_ | 1797924669695721472 |
|---|---|
| author | Sara Pedron Michael Hanselmann Jacob Burns Alexander Rich Annette Peters Margit Heier Lars Schwettmann Jacob H Bor Till Bärnighausen Michael Laxy |
| author_facet | Sara Pedron Michael Hanselmann Jacob Burns Alexander Rich Annette Peters Margit Heier Lars Schwettmann Jacob H Bor Till Bärnighausen Michael Laxy |
| author_sort | Sara Pedron |
| collection | DOAJ |
| description | <h4>Background</h4>Hypertension represents one of the major risk factors for cardiovascular morbidity and mortality globally. Early detection and treatment of this condition is vital to prevent complications. However, hypertension often goes undetected, and even if detected, not every patient receives adequate treatment. Identifying simple and effective interventions is therefore crucial to fight this problem and allow more patients to receive the treatment they need. Therefore, we aim at investigating the impact of a population-based blood pressure (BP) screening and the subsequent "low-threshold" information treatment on long-term cardiovascular disease (CVD) morbidity and mortality.<h4>Methods and findings</h4>We examined the impact of a BP screening embedded in a population-based cohort study in Germany and subsequent personalized "light touch" information treatment, including a hypertension diagnosis and a recommendation to seek medical attention. We pooled four waves of the KORA study, carried out between 1984 and 1996 (N = 14,592). Using a sharp multivariate regression discontinuity (RD) design, we estimated the impact of the information treatment on CVD mortality and morbidity over 16.9 years. Additionally, we investigated potential intermediate outcomes, such as hypertension awareness, BP, and behavior after 7 years. No evidence of effect of BP screening was observed on CVD mortality (hazard ratio (HR) = 1.172 [95% confidence interval (CI): 0.725, 1.896]) or on any (fatal or nonfatal) long-term CVD event (HR = 1.022 [0.636, 1.641]) for individuals just above (versus below) the threshold for hypertension. Stratification for previous self-reported diagnosis of hypertension at baseline did not reveal any differential effect. The intermediate outcomes, including awareness of hypertension, were also unaffected by the information treatment. However, these results should be interpreted with caution since the analysis might not be sufficiently powered to detect a potential intervention effect.<h4>Conclusions</h4>The study does not provide evidence of an effect of the assessed BP screening and subsequent information treatment on BP, health behavior, or long-term CVD mortality and morbidity. Future studies should consider larger datasets to detect possible effects and a shorter follow-up for the intermediate outcomes (i.e., BP and behavior) to detect short-, medium-, and long-term effects of the intervention along the causal pathway. |
| first_indexed | 2024-04-10T15:05:45Z |
| format | Article |
| id | doaj.art-c9ab736b112b458ba8297ca40d1f6593 |
| institution | Directory Open Access Journal |
| issn | 1549-1277 1549-1676 |
| language | English |
| last_indexed | 2024-04-10T15:05:45Z |
| publishDate | 2022-12-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Medicine |
| spelling | doaj.art-c9ab736b112b458ba8297ca40d1f65932023-02-15T05:30:32ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762022-12-011912e100415110.1371/journal.pmed.1004151The effect of population-based blood pressure screening on long-term cardiometabolic morbidity and mortality in Germany: A regression discontinuity analysis.Sara PedronMichael HanselmannJacob BurnsAlexander RichAnnette PetersMargit HeierLars SchwettmannJacob H BorTill BärnighausenMichael Laxy<h4>Background</h4>Hypertension represents one of the major risk factors for cardiovascular morbidity and mortality globally. Early detection and treatment of this condition is vital to prevent complications. However, hypertension often goes undetected, and even if detected, not every patient receives adequate treatment. Identifying simple and effective interventions is therefore crucial to fight this problem and allow more patients to receive the treatment they need. Therefore, we aim at investigating the impact of a population-based blood pressure (BP) screening and the subsequent "low-threshold" information treatment on long-term cardiovascular disease (CVD) morbidity and mortality.<h4>Methods and findings</h4>We examined the impact of a BP screening embedded in a population-based cohort study in Germany and subsequent personalized "light touch" information treatment, including a hypertension diagnosis and a recommendation to seek medical attention. We pooled four waves of the KORA study, carried out between 1984 and 1996 (N = 14,592). Using a sharp multivariate regression discontinuity (RD) design, we estimated the impact of the information treatment on CVD mortality and morbidity over 16.9 years. Additionally, we investigated potential intermediate outcomes, such as hypertension awareness, BP, and behavior after 7 years. No evidence of effect of BP screening was observed on CVD mortality (hazard ratio (HR) = 1.172 [95% confidence interval (CI): 0.725, 1.896]) or on any (fatal or nonfatal) long-term CVD event (HR = 1.022 [0.636, 1.641]) for individuals just above (versus below) the threshold for hypertension. Stratification for previous self-reported diagnosis of hypertension at baseline did not reveal any differential effect. The intermediate outcomes, including awareness of hypertension, were also unaffected by the information treatment. However, these results should be interpreted with caution since the analysis might not be sufficiently powered to detect a potential intervention effect.<h4>Conclusions</h4>The study does not provide evidence of an effect of the assessed BP screening and subsequent information treatment on BP, health behavior, or long-term CVD mortality and morbidity. Future studies should consider larger datasets to detect possible effects and a shorter follow-up for the intermediate outcomes (i.e., BP and behavior) to detect short-, medium-, and long-term effects of the intervention along the causal pathway.https://doi.org/10.1371/journal.pmed.1004151 |
| spellingShingle | Sara Pedron Michael Hanselmann Jacob Burns Alexander Rich Annette Peters Margit Heier Lars Schwettmann Jacob H Bor Till Bärnighausen Michael Laxy The effect of population-based blood pressure screening on long-term cardiometabolic morbidity and mortality in Germany: A regression discontinuity analysis. PLoS Medicine |
| title | The effect of population-based blood pressure screening on long-term cardiometabolic morbidity and mortality in Germany: A regression discontinuity analysis. |
| title_full | The effect of population-based blood pressure screening on long-term cardiometabolic morbidity and mortality in Germany: A regression discontinuity analysis. |
| title_fullStr | The effect of population-based blood pressure screening on long-term cardiometabolic morbidity and mortality in Germany: A regression discontinuity analysis. |
| title_full_unstemmed | The effect of population-based blood pressure screening on long-term cardiometabolic morbidity and mortality in Germany: A regression discontinuity analysis. |
| title_short | The effect of population-based blood pressure screening on long-term cardiometabolic morbidity and mortality in Germany: A regression discontinuity analysis. |
| title_sort | effect of population based blood pressure screening on long term cardiometabolic morbidity and mortality in germany a regression discontinuity analysis |
| url | https://doi.org/10.1371/journal.pmed.1004151 |
| work_keys_str_mv | AT sarapedron theeffectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT michaelhanselmann theeffectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT jacobburns theeffectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT alexanderrich theeffectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT annettepeters theeffectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT margitheier theeffectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT larsschwettmann theeffectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT jacobhbor theeffectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT tillbarnighausen theeffectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT michaellaxy theeffectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT sarapedron effectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT michaelhanselmann effectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT jacobburns effectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT alexanderrich effectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT annettepeters effectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT margitheier effectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT larsschwettmann effectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT jacobhbor effectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT tillbarnighausen effectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis AT michaellaxy effectofpopulationbasedbloodpressurescreeningonlongtermcardiometabolicmorbidityandmortalityingermanyaregressiondiscontinuityanalysis |